Exelixis, Inc. v. Biocon Pharma Limited et al
| Exelixis, Inc. |
| Biocon Pharma Limited, Biocon Pharma, Inc. and Biocon Limited |
| Biocon Limited, Biocon Pharma Limited and Biocon Pharma, Inc. |
| Exelixis, Inc. |
| 1:2025cv00452 |
| April 11, 2025 |
| U.S. District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 5, 2025. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 30 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776; 11,091,439; 11,091,440; 11,098,015; 12,128,039. (Attachments: #1 Order)(nms) |
Filing 29
SO ORDERED Granting #28 Order and Stipulation of Dismissal without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/5/2025. (nms)
|
| Filing 28 PROPOSED Order and Stipulation of Dismissal Without Prejudice, by Exelixis, Inc.. (Raucci, Anthony) Modified on 9/5/2025 (nms). |
| Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 7/24/2025. Local counsel for Plaintiff: A. Raucci. Local counsel for Defendants: D. Gattuso (MSN), S. Metzler (Sun), K. Dorsney (Azurity). Plaintiff is to resubmit the final scheduling order. (Court Reporter Deanna Warner.) (aas) |
|
Filing 27
ORAL ORDER: The Biocon defendants request to be excused from the Rule 16(b) Conference scheduled for 7/24/2025, is GRANTED. Ordered by Judge Richard G. Andrews on 7/23/2025. Associated Cases: 1:24-cv-01208-RGA, 1:25-cv-00346-RGA, 1:25-cv-00423-RGA, 1:25-cv-00452-RGA, 1:25-cv-00478-RGA(nms)
|
| Filing 26 Letter to The Honorable Richard G. Andrews, from Anthony D. Raucci, regarding Proposed Scheduling Order. (Raucci, Anthony) Modified on 7/23/2025 (nms). |
|
Filing 25
SO ORDERED Granting #24 Stipulation and Proposed Order to Stay (*Set Deadlines: ( Status Report due by 9/5/2025). Signed by Judge Richard G. Andrews on 7/22/2025. (nms)
|
| Filing 24 STIPULATION and [Proposed] Order to Stay, by Exelixis, Inc.. (Raucci, Anthony) Modified on 7/21/2025 (nms). |
| Filing 23 Pro Hac Vice Fee - Credit Card Payment received for Steven A. Maddox. ( re #22 MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox )( Payment of $ 50, receipt number ADEDC-4735215).(Haney, Megan) |
| Filing 22 MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox - filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Attachments: #1 Certification of Steven A. Maddox)(Haney, Megan) |
| Pro Hac Vice Attorney Steven A. Maddox for Biocon Limited, Biocon Pharma Limited & Biocon Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
|
SO ORDERED, re #22 MOTION for Pro Hac Vice Appearance of Attorney Steven A. Maddox filed by Biocon Limited, Biocon Pharma, Inc., Biocon Pharma Limited. Signed by Judge Richard G. Andrews on 7/16/2025. (aas)
|
| Filing 21 ANSWER to #15 Answer to Complaint and Counterclaims, by Exelixis, Inc..(Raucci, Anthony) Modified on 7/11/2025 (nms). |
| Filing 20 Pro Hac Vice Fee - Credit Card Payment received for Jeremy J. Edwards. ( re #19 MOTION for Pro Hac Vice Appearance of Attorney Jeremy J. Edwards )( Payment of $ 50, receipt number ADEDC-4723275).(Phillips, John) |
| Filing 19 MOTION for Pro Hac Vice Appearance of Attorney Jeremy J. Edwards - filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Attachments: #1 Certification of Jeremy J. Edwards)(Phillips, John) |
| Pro Hac Vice Attorney Jeremy J. Edwards for Biocon Limited, Biocon Pharma Limited, and Biocon Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (jn) |
|
SO ORDERED, re #19 MOTION for Pro Hac Vice Appearance of Attorney Jeremy J. Edwards filed by Biocon Limited, Biocon Pharma, Inc., Biocon Pharma Limited. Signed by Judge Richard G. Andrews on 7/1/2025. (aas)
|
|
Filing 18
Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 7/24/2025, at 3:30 PM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/30/2025. (nms)
|
| Filing 17 NOTICE of Appearance by Megan C. Haney on behalf of All Defendants (Haney, Megan) |
| Filing 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biocon Limited for Biocon Pharma Limited; Corporate Parent Biocon Pharma Limited for Biocon Pharma, Inc. filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Phillips, John) |
| Filing 15 ANSWER to #1 Complaint and COUNTERCLAIMS against Exelixis, Inc., by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc..(Phillips, John) Modified on 6/20/2025 (nms). |
| Filing 14 Unopposed Motion to Extend Time to Respond to Complaint - filed by Exelixis, Inc.. (Raucci, Anthony) Modified on 6/2/2025 (nms). |
|
SO ORDERED, re #14 Unopposed Motion to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Biocon Limited answer due 6/19/2025; Biocon Pharma Limited answer due 6/19/2025; Biocon Pharma, Inc. answer due 6/19/2025). Signed by Judge Richard G. Andrews on 6/2/2025. (nms)
|
| Filing 13 Unopposed Motion to Extend Time to Respond to Complaint - filed by Exelixis, Inc.. (Raucci, Anthony) Modified on 5/2/2025 (nms). |
|
SO ORDERED, re #13 Unopposed Motion to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Biocon Limited answer due 6/5/2025; Biocon Pharma Limited answer due 6/5/2025; Biocon Pharma, Inc. answer due 6/5/2025). Signed by Judge Richard G. Andrews on 5/2/2025. (nms)
|
| Pro Hac Vice Attorney Alexander Gorka, Anna Mizzi, Cindy Kan, Gerard A. Salvatore, Amy K. Wigmore, Jonathan A. Cox, Kevin S. Prussia, Emily R. Whelan, Lisa J. Pirozzolo for Exelixis, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:25-cv-00346-RGA, 1:25-cv-00423-RGA, 1:25-cv-00452-RGA(cdd) |
| Filing 12 Pro Hac Vice Fee - Credit Card Payment received for Gerard A. Salvatore, Cindy Kan, Anna Mizzi, and Alexander P. Gorka. ( re #10 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Jonathan A. Cox, Amy K. Wigmore, Gerard A. Salvatore, Cindy Kan, Anna Mizzi, and Alexander P. Gorka )( Payment of $ 200, receipt number ADEDC-4674576).(Raucci, Anthony) |
| Filing 11 Pro Hac Vice Fee - Credit Card Payment received for Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Jonathan A. Cox, and Amy K. Wigmore. ( re #10 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Jonathan A. Cox, Amy K. Wigmore, Gerard A. Salvatore, Cindy Kan, Anna Mizzi, and Alexander P. Gorka )( Payment of $ 250, receipt number ADEDC-4674574).(Raucci, Anthony) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Jonathan A. Cox, Amy K. Wigmore, Gerard A. Salvatore, Cindy Kan, Anna Mizzi, and Alexander P. Gorka - filed by Exelixis, Inc.. (Raucci, Anthony) |
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Lisa J. Pirozzolo, Emily R. Whelan, Kevin S. Prussia, Jonathan A. Cox, Amy K. Wigmore, Gerard A. Salvatore, Cindy Kan, Anna Mizzi, and Alexander P. Gorka filed by Exelixis, Inc.. Signed by Judge Richard G. Andrews on 4/30/2025. (aas)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (alb) |
| Filing 9 SUMMONS Returned Executed by Exelixis, Inc..Biocon Pharma, Inc. served on 4/15/2025, answer due 5/6/2025. (Raucci, Anthony) |
| Filing 8 SUMMONS Returned Executed by Exelixis, Inc..Biocon Limited served on 4/15/2025, answer due 5/6/2025. (Raucci, Anthony) |
| Filing 7 SUMMONS Returned Executed by Exelixis, Inc..Biocon Pharma Limited served on 4/15/2025, answer due 5/6/2025. (Raucci, Anthony) |
| Filing 6 Summons Issued as to Biocon Limited on 4/14/2025; Biocon Pharma Limited on 4/14/2025; Biocon Pharma, Inc. on 4/14/2025. (Attachments: #1 Summons Issued, #2 Summons Issued)(mrr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (mrr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,877,776; 11,091,439; 11,091,440; 11,098,015 ; 12,128,039. (mrr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/04/2025. Date of Expiration of Patent: U.S. Patent Nos. 8,877,776 expires on 10/08/2030; U.S. Patent Nos. 11,091,439, 11,091,440, and 11,098,015 expire on 01/15/2030; and U.S. Patent No. 12,128,039 expires on 02/10/2032.Thirty Month Stay Deadline: 9/4/2027. (mrr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) |
| Filing 1 COMPLAINT for Patent Infringement against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4660524) - filed by Exelixis, Inc. (Attachments: #1 Exhibits A-E, #2 Civil Cover Sheet)(mrr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
